Infographic | December 6, 2023

For The Record: An Overview Of CAR-T Trials By Clinical Phase Of Development For Hematological And Solid Tumors

Cell therapies have become a highly active area of clinical development in oncology with CAR-T therapies being the most advanced. The first CAR-T therapies were approved in the U.S. in 2017, followed by approvals in the EU and Japan in 2018 and 2019 respectively. China had its first approval in 2021.

access the Infographic!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)